logo-loader
Tech
viewDeepMatter Group PLC

DeepMatter Group helping to make drugs 'faster, cheaper and more cost effectively'

DeepMatter Group PLC's (LON:DMTR) Mark Warne introduces the business to Proactive London's Andrew Scott and talks through the firm's interim results to June 2019.

''What we're trying to do is address a $28bn problem to improve re-produceability in science so ultimately drugs can be made faster, cheaper and more cost-effectively'' 

''The business was spun out of the University of Glasgow at the back end of 2014, we've grown our Deepmatter platform over the last two or three years .... and now we're generating our first revenues''. 

Quick facts: DeepMatter Group PLC

Price: 2.9 GBX

AIM:DMTR
Market: AIM
Market Cap: £21.36 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks quiet into the weekend after milestone week in...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada fell 1.6% to 139.34 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 2.5% to C$10.77, while the OTCQX Cannabis Index sank 1.5% to...

1 day, 22 hours ago

2 min read